Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin alfa + Radiotherapy in Anemic Head and Neck Cancer
NCT00004917Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Jun 2000
- Primary completion
- Nov 2007
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 3
01
Overview
A Phase 3 trial of epoetin alfa in head and neck squamous cell carcinoma (HNSCC), anemia, sponsored by NRG Oncology. Started Jun 2000; status: completed.
02
Drugs
epoetin alfa
03
Conditions
head and neck squamous cell carcinoma (HNSCC)anemia
Beyond the preview
Go deeper on NCT00004917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004917.